These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35980535)

  • 1. Evaluation of galectin-3 and intestinal fatty acid binding protein as serum biomarkers in autosomal recessive polycystic kidney disease.
    Fleischer LT; Ballester L; Dutt M; Howarth K; Poznick L; Darge K; Furth SL; Hartung EA
    J Nephrol; 2023 Jan; 36(1):133-145. PubMed ID: 35980535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound Elastography to Quantify Liver Disease Severity in Autosomal Recessive Polycystic Kidney Disease.
    Hartung EA; Wen J; Poznick L; Furth SL; Darge K
    J Pediatr; 2019 Jun; 209():107-115.e5. PubMed ID: 30902421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease.
    Gunay-Aygun M; Font-Montgomery E; Lukose L; Tuchman Gerstein M; Piwnica-Worms K; Choyke P; Daryanani KT; Turkbey B; Fischer R; Bernardini I; Sincan M; Zhao X; Sandler NG; Roque A; Douek DC; Graf J; Huizing M; Bryant JC; Mohan P; Gahl WA; Heller T
    Gastroenterology; 2013 Jan; 144(1):112-121.e2. PubMed ID: 23041322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance elastography to quantify liver disease severity in autosomal recessive polycystic kidney disease.
    Hartung EA; Calle-Toro JS; Lopera CM; Wen J; Carson RH; Dutt M; Howarth K; Furth SL; Darge K; Serai SD
    Abdom Radiol (NY); 2021 Feb; 46(2):570-580. PubMed ID: 32757071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term kidney and liver outcome in 50 children with autosomal recessive polycystic kidney disease.
    Dorval G; Boyer O; Couderc A; Delbet JD; Heidet L; Debray D; Krug P; Girard M; Llanas B; Charbit M; Krid S; Biebuyck N; Fila M; Courivaud C; Tilley F; Garcelon N; Blanc T; Chardot C; Salomon R; Lacaille F
    Pediatr Nephrol; 2021 May; 36(5):1165-1173. PubMed ID: 33165639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-dimensional (2D) morphologic measurements can quantify the severity of liver disease in children with autosomal recessive polycystic kidney disease (ARPKD).
    Ghosh A; Serai SD; Venkatakrishna SSB; Dutt M; Hartung EA
    Abdom Radiol (NY); 2021 Oct; 46(10):4709-4719. PubMed ID: 34173844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic characteristics of autosomal recessive polycystic kidney disease in Oman.
    Al Alawi I; Molinari E; Al Salmi I; Al Rahbi F; Al Mawali A; Sayer JA
    BMC Nephrol; 2020 Aug; 21(1):347. PubMed ID: 32799815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of serum galectin-3 level with renal volume and function in adult polycystic kidney disease.
    Ozkurt S; Dogan I; Ozcan O; Fidan N; Bozaci I; Yilmaz B; Bilgin M
    Int Urol Nephrol; 2019 Jul; 51(7):1191-1197. PubMed ID: 31012038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined liver-kidney transplantation for children with autosomal recessive polycystic kidney disease (ARPKD): indication and outcome.
    Brinkert F; Lehnhardt A; Montoya C; Helmke K; Schaefer H; Fischer L; Nashan B; Bergmann C; Ganschow R; Kemper MJ
    Transpl Int; 2013 Jun; 26(6):640-50. PubMed ID: 23582048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital hepatic fibrosis and autosomal recessive polycystic kidney disease.
    Srinath A; Shneider BL
    J Pediatr Gastroenterol Nutr; 2012 May; 54(5):580-7. PubMed ID: 22197937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney Disease Progression in Autosomal Recessive Polycystic Kidney Disease.
    Dell KM; Matheson M; Hartung EA; Warady BA; Furth SL;
    J Pediatr; 2016 Apr; 171():196-201.e1. PubMed ID: 26831744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of kidney and liver disease in autosomal recessive polycystic kidney disease-congenital hepatic fibrosis.
    Abdul Majeed N; Font-Montgomery E; Lukose L; Bryant J; Veppumthara P; Choyke PL; Turkbey IB; Heller T; Gahl WA; Gunay-Aygun M
    Mol Genet Metab; 2020; 131(1-2):267-276. PubMed ID: 32919899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD).
    Adeva M; El-Youssef M; Rossetti S; Kamath PS; Kubly V; Consugar MB; Milliner DM; King BF; Torres VE; Harris PC
    Medicine (Baltimore); 2006 Jan; 85(1):1-21. PubMed ID: 16523049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypomagnesaemia is absent in children with autosomal dominant polycystic kidney disease.
    Seeman T; Fořtová M; Sopko B; Průša R; Pohl M; John U
    Ann Clin Biochem; 2019 Jan; 56(1):90-94. PubMed ID: 29874928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of transjugular intrahepatic portosystemic shunt for portal hypertension in autosomal recessive polycystic kidney disease.
    Verbeeck S; Mekhali D; Cassiman D; Maleux G; Witters P
    Dig Liver Dis; 2018 Jul; 50(7):707-712. PubMed ID: 29622386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognition in children with autosomal recessive polycystic kidney disease in the CKiD cohort study.
    Hartung EA; Matheson M; Lande MB; Dell KM; Guay-Woodford LM; Gerson AC; Warady BA; Hooper SR; Furth SL
    Pediatr Nephrol; 2014 Oct; 29(10):1957-65. PubMed ID: 24828609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial evaluation of hepatic T1 relaxation time as an imaging marker of liver disease associated with autosomal recessive polycystic kidney disease (ARPKD).
    Gao Y; Erokwu BO; DeSantis DA; Croniger CM; Schur RM; Lu L; Mariappuram J; Dell KM; Flask CA
    NMR Biomed; 2016 Jan; 29(1):84-9. PubMed ID: 26608869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
    Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT
    Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of liver-type fatty acid binding protein (L-FABP) and interleukin 6 in children with renal cysts.
    Plesiński K; Adamczyk P; Świętochowska E; Morawiec-Knysak A; Gliwińska A; Korlacki W; Szczepańska M
    Adv Clin Exp Med; 2019 Dec; 28(12):1675-1682. PubMed ID: 31778601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient Elastography for Detection of Liver Fibrosis in Children With Autosomal Recessive Polycystic Kidney Disease.
    Wicher D; Jankowska I; Lipiński P; Szymańska-Rożek P; Kmiotek J; Jańczyk W; Rubik J; Chrzanowska K; Socha P
    Front Pediatr; 2018; 6():422. PubMed ID: 30687687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.